Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.

Transforming growth factor beta (TGF-beta) exhibits diverse effects on growth and differentiation of a wide range of cell types. In the immune system, TGF-beta 1 is a potent inhibitor of T cell proliferation and certain T cell effector functions. However, TGF-beta 1 also enhances growth of T cells, predominantly of naive phenotype, and induces their expression of selected cytokines. We have previously demonstrated that TGF-beta 1 costimulates growth of highly purified murine CD8+ T cells activated by immobilized anti-CD3 Ab. TGF-beta 1-costimulated CD8+ T cells rapidly express a memory phenotype, lose lytic function, and express a mixed cytokine pattern with IL-2, IFN-gamma, and appreciable IL-10, as well as TGF-beta 1. The present work examines the possibility that TGF-beta 1 similarly costimulates response of murine CD8+ T cells to the microbial superantigen staphylococcal enterotoxin B (SEB) and characterizes their effector and regulatory functions. TGF-beta 1 significantly enhances CD8+ T cell proliferation to SEB in the presence of MHC class II-positive APC and TGF-beta 1-primed CD8+ T cells are enriched for SEB-reactive V beta 8+ TCR expression. TGF-beta 1 priming also up-regulates a memory-like CD45RBlowCD44highMEL-14low phenotype. TGF-beta 1 priming inhibits development of SEB-specific lytic effector function by more than 90%. However, TGF-beta 1-primed CD8+ effector T cells express elevated levels of IL-10 and TGF-beta 1, variable IFN-gamma, and undetectable IL-4. Additionally, they exhibit growth inhibitory effector function of SEB-induced proliferation of other CD4+ and CD8+ T cells. Growth inhibition by TGF-beta 1-primed CD8+ T cells is reversed in part by anti-IL-10 Ab. Thus, in the context of SEB response, TGF-beta 1 promotes the outgrowth and induces the effector function of CD8+ T cells that have the capacity to impair T cell clonal growth.

• Publication year

  1995

• Venue

  Journal of Immunology

• Publication date

  1995-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.155.2.609PMID 7608539
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of transforming growth factor beta in the generation of suppression: an interaction between CD8+ T and NK cells

  1994cited by this paper
• Acquisition of lymphokine-producing phenotype by CD4+ T cells.

  1994cited by this paper
• TGF-beta promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms.

  1994cited by this paper
• Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles

  1994cited by this paper
• In vitro maturation of human neonatal CD4 T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine production.

  1994cited by this paper
• Differential effect of transforming growth factor-beta 1 on the activation of human naive and memory CD4+ T lymphocytes.

  1994cited by this paper
• Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype.

  1994cited by this paper
• Endogenous retroviral superantigen presentation by B cells induces the development of type 1 CD4+ T helper lymphocytes

  1993cited by this paper
• Distinction of mouse CD8+ suppressor effector T cell clones from cytotoxic T cell clones by cytokine production and CD45 isoforms.

  1993cited by this paper
• Study of activation of murine T cells with bacterial superantigens. In vitro induction of enhanced responses in CD4+ T cells and of anergy in CD8+ T cells.

  1993cited by this paper
• Role of transforming growth factor-beta in the preferential induction of T helper cells of type 1 by staphylococcal enterotoxin B.

  1993cited by this paper
• Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells.

  1993cited by this paper
• Effect of transforming growth factor-beta on early and late activation events in human T cells.

  1993cited by this paper
• IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.

  1993cited by this paper
• Differential activation of CD8+ T cells by transforming growth factor-beta 1.

  1993cited by this paper
• Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.

  1993cited by this paper
• Pathogen-induced Th1 phenotype development in CD4+ alpha beta-TCR transgenic T cells is macrophage dependent.

  1993cited by this paper
• Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes.

  1992cited by this paper
• Differential effect of transforming growth factor β on the synthesis of Th1‐ and Th2‐like lymphokines by human T lymphocytes

  1992cited by this paper
• Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.

  1992cited by this paper
• Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype.

  1991cited by this paper
• Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

  1991cited by this paper
• Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta.

  1991cited by this paper
• Superantigens: mechanism of T-cell stimulation and role in immune responses.

  1991cited by this paper
• Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones.

  1991cited by this paper
• Co-stimulation of T cell proliferation by transforming growth factor-beta 1.

  1991cited by this paper
• Programmed cell death and extrathymic reduction of Vβ8+CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B

  1991cited by this paper
• Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.

  1990cited by this paper
• Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells.

  1990cited by this paper
• Regulation of interleukin-2 and interleukin-6 production from T-cells: involvement of interleukin-1 beta and transforming growth factor-beta.

  1990cited by this paper
• Multiple suppressive effects of transforming growth factor beta 1 on the immune response in chickens.

  1990cited by this paper
• Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice.

  1989cited by this paper
• Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation.

  1988cited by this paper
• The glioblastoma‐derived t cell suppressor factor/ transforming growth factor‐β2 inhibits t cell growth without affecting the interaction of interleukin 2 with its receptor

  1988cited by this paper
• Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

  1987cited by this paper
• Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

  1987cited by this paper
• Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

  1986cited by this paper

• Optimising Chemotherapy for Advanced High-Grade Serous Ovarian Cancer via Delay-Differential Equations

  2025cites this paper
• TGF-β signaling in health, disease and therapeutics

  2024cites this paper
• The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial

  2024cites this paper
• IL-10 Negatively Controls the Primary T Cell Response of Tilapia by Triggering the JAK1/STAT3/SOCS3 Axis That Suppresses NF-κB and MAPK/ERK Signaling.

  2022cites this paper
• The rs3761548 FOXP3 variant is associated with multiple sclerosis and transforming growth factor β1 levels in female patients

  2019cites this paper
• Limited in Nonautoimmune Mice Induction of Autoantibody Production Is

  2017cites this paper
• The effects of oocytes on Smad signaling pathways in granulosa cells

  2017cites this paper
• Regulatory T Cells: Translational Immunology: Mechanisms and Pharmacologic Approaches

  2016cites this paper
• Predominance of Weakly Cytotoxic, T-betLowEomesNeg CD8+ T-cells in Human Gastrointestinal Mucosa: Implications for HIV Infection

  2016influential citation
• Advances in molecular and immunologic targeted therapies for squamous cell carcinoma of the lung

  2015cites this paper
• Purified Dendritic Cell-Tumor Fusion Hybrids Supplemented with Non-Adherent Dendritic Cells Fraction Are Superior Activators of Antitumor Immunity

  2014cites this paper
• TGF-β: Guardian of T Cell Function

  2013cites this paper
• Immune Mechanisms of Extracellular Matrix Remodeling in the Common Carotid: A Model of Intimal Hyperplasia

  2012cites this paper
• Peripheral biomarkers for individualizing immunosuppression in transplantation--regulatory T cells.

  2012cites this paper
• TGF-β1 Induces Preferential Rapid Expansion and Persistence of Tumor Antigen-specific CD8+ T Cells for Adoptive Immunotherapy

  2010cites this paper
• Stem Cell and Biological Interventions to treat Allergic Airway Disease

  2010cites this paper
• Cutting Edge: Tumor-Specific CD8+ T Cells Infiltrating Prostatic Tumors Are Induced to Become Suppressor Cells1

  2009cites this paper
• TGF-β and Regulatory T Cell in Immunity and Autoimmunity

  2008influential citation
• Expression of a Soluble TGF-β Receptor by Tumor Cells Enhances Dendritic Cell/Tumor Fusion Vaccine Efficacy1

  2008cites this paper
• Expression on Effector CD 8 Cells Is Associated with Increased PD-1 T + Presence of Suppressor HIV-Specific CD 8

  2008cites this paper
• Presence of Suppressor HIV-Specific CD8+ T Cells Is Associated with Increased PD-1 Expression on Effector CD8+ T Cells1

  2008cites this paper
• CD8+ suppressor T cells resurrected.

  2008cites this paper
• TGF-Beta and Regulatory T Cells

  2008cites this paper
• Special regulatory T‐cell review: suppressors regulated but unsuppressed 1

  2008cites this paper
• Costimulatory strength influences the differential effects of transforming growth factor beta1 for the generation of CD8+ regulatory T cells.

  2008cites this paper
• ‘Yin–Yang’ functions of transforming growth factor‐β and T regulatory cells in immune regulation

  2007cites this paper
• Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10

  2007cites this paper
• The roles for cytokines in the generation and maintenance of regulatory T cells

  2006influential citation
• Latent TGF‐β1‐transduced CD4+ T cells suppress the progression of allergic encephalomyelitis

  2006cites this paper
• TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection.

  2006cites this paper
• TGFβ Protein Processing and Activity through TCR Triggering of Primary CD8+ T Regulatory Cells1

  2006cites this paper
• Cytokines in idiopathic inflammatory myopathies

  2006cites this paper
• Cytokine responses in metal-induced allergic contact dermatitis: Relationship to in vivo responses and implication for in vitro diagnosis

  2005cites this paper
• Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.

  2004cites this paper
• The role of the combination of IL‐2 and TGF‐β or IL‐10 in the generation and function of CD4+ CD25+ and CD8+regulatory T cell subsets

  2003cites this paper
• Tumor-Derived TGF-β Reduces the Efficacy of Dendritic Cell/Tumor Fusion Vaccine1

  2003cites this paper
• Induction of Autoantibody Production Is Limited in Nonautoimmune Mice1

  2002cites this paper
• DNA microarray analysis of the gene expression profiles of naïve versus activated tumor-specific T cells.

  2002cites this paper
• Vaccination with Minigenes Encoding VH-derived Major Histocompatibility Complex Class I–binding Epitopes Activates Cytotoxic T Cells that Ablate Autoantibody-producing B Cells and Inhibit Lupus

  2002cites this paper
• The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases

  2002cites this paper
• Chronic exposure to superantigen induces regulatory CD4(+) T cells with IL-10-mediated suppressive activity.

  2001cites this paper
• Tumor-derived TGF-beta reduces the efficacy of dendritic cell/tumor fusion vaccine.

  2001cites this paper
• CD8(+) T cells from Theiler's virus-resistant BALB/cByJ mice downregulate pathogenic virus-specific CD4(+) T cells.

  2000cites this paper
• Rôle des cytokines dans la physiopathologie du lupus

  2000cites this paper
• Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease.

  1999cites this paper
• Production in Atopic Dermatitis Contribute to Eosinophilia and IgE T Cells Respond to Superantigen and + CD 8 Lymphocyte-Associated Antigen-Positive ) Skin Homing ( Cutaneous

  1999cites this paper
• Effect of Transforming Growth Factor β on Experimental Salmonella typhimurium Infection in Mice

  1999cites this paper
• Modulation by cytokines of induction of oral tolerance to type II collagen.

  1999cites this paper
• Inhibitory effects of transforming growth factor‐beta (TGF‐β) on certain functions of intraepithelial lymphocytes

  1999cites this paper
• Transforming growth factor-beta1, a strong costimulator of rat T-cell activation promoting a shift towards a Th2-like cytokine profile.

  1999cites this paper
• Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis.

  1999cites this paper
• TGF-beta1: immunosuppressant and viability factor for T lymphocytes.

  1999cites this paper
• TGF-β1: immunosuppressant and viability factor for T lymphocytes

  1999cites this paper
• Natural Killer Cells and CD8+ T Cells in the Downregulation of Antibody Production in Healthy Subjects and SLE

  1999cites this paper
• Effect of transforming growth factor beta on experimental Salmonella typhimurium infection in mice.

  1999cites this paper
• Synergism of the malononitrilamides 279 and 715 with cyclosporine A in the induction of long‐term cardiac allograft survival

  1998cites this paper
• Role of Type I (Neuronal) Nitric Oxide Synthase in Pulmonary Vascular Tone in the Ovine Fetus ♦ 348

  1998cites this paper
• The Three Isoforms of Transforming Growth Factor‐β Co‐stimulate Rat T Cells and Inhibit Lymphocyte Apoptosis

  1998cites this paper
• Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1.

  1998cites this paper
• Characterization of erythroid cell-derived natural suppressor activity.

  1998cites this paper
• Transforming Growth Factor-β Levels in Maternal Milk and Expression in Postnatal Rat Duodenum and Ileum

  1998cites this paper
• Synergism of the malononitrilamides 279 and 715 with cyclosporine A in the induction of long-term cardiac allograft survival

  1998cites this paper
• Cytokine Gene Transcription in Simian Immunodeficiency Virus and Human Immunodeficiency Virus-Associated Non-Hodgkin Lymphomas

  1997cites this paper
• Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

  1997cites this paper
• Monocyte‐Dependent Costimulatory Effect of TGF‐β1 on Rat T‐Cell Activation

  1996cites this paper
• Role of alpha 5 beta 1 integrin in TGF-beta 1-costimulated CD8+ T cell growth and apoptosis.

  1996cites this paper
• The emergence of non‐cytolytic NK1.1+ T cells in the long‐term culture of murine tumour‐infiltrating lymphocytes: a possible role of transforming growth factor‐β

  1996cites this paper